Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma

Clinical Trial ID NCT00248534

PubWeight™ 2.15‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00248534

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol 2013 1.56
2 Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leuk Lymphoma 2012 0.87
Next 100